(Q66077190)
Statements
A Phase 1 Randomized, Controlled, Double-Blind, Single Ascending Dose Safety and Pharmacokinetic/Pharmacodynamic Study in Healthy Adult Males After LIQ865 Injection (English)
0 references
5 December 2016
0 references
23 March 2017
0 references
29
0 references
18 year
0 references
45 year
0 references